World Pharmaceutical Frontiers presents 2010’s top 40 most influential people in the industry, as judged by our panel of industry experts. Editor Andrew Tunnicliffe takes stock of the ups and downs in what has been a turbulent year for everyone.
3. Jeffrey Kindler (39º en 2009)
Appointed CEO of one of the biggest pharma companies in the world back in 2006, Kindler has presided over the company during a year when it was fined $1.8 billion by the US government for “misleading” sales advice, and swallowed up one of its rivals, Wyeth, in a $68 billion deal. In recent months Kindler has become more vocal on a number of issues including stepping up support for US healthcare reform, which he hopes will help address the inequalities in the US healthcare system, and bringing in new laws that will help regulate generics whilst fostering a culture of innovation.
01 Ada Yonath
Yonath’s most notable success came in 2009 when she was awarded the Nobel Prize in Chemistry along with Venkatraman Ramakrishnan and Thomas A. Steitz for discovering the structure of ribosomes, a potential target for drug discovery and metabolism. The Israeli-born crystallographer became the first woman in 45 years to win the prize for sciences and the first-ever female Israeli to be awarded a Nobel Prize.
13. Dr Margaret Chan (13º en 2009)
Chan was appointed to her position in 2006 and since then has faced a number of issues. None have been as big as this past year; the first pandemic of the 21st century. The WHO coordinated the global response, collated statistics and managed the public, commercial and NGO response.
4. Bill and Melinda Gates (6º en 2009)
While their Foundation continues to support work in public health both inside the US and around the world there has been a little more emphasis put on other social projects in teaching, housing, technology and an array of other areas. The foundation recently committed itself to working with the Obama Administration on its six-year, $63 billion Global Health Initiative which, among other things, aims to combat AIDS, TB and malaria, as well as increasing access to care for women and children. In one of its latest commitments, Bill and Melinda told the Davos summit the foundation was pledging $10 billion over the coming decade to help fund R&D into vaccines.
18º (10) Arthur Levinson, former chairman and CEO, Genentech
21º (26) Chris Viehbacher, CEO, Sanofi Aventis
22º (05) Shlomo Yanai, president and CEO, Teva Pharmaceuticals
26º (25) James M Cornelius, chairman and CEO, Bristol Myers Squibb
32º (09) Daniel Vasella, chairman and CEO, Novartis
(año anterior)
Entradas
No hay comentarios:
Publicar un comentario